These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2508379)

  • 1. [Immunosuppressive action of the lethal toxin of Bacillus anthracis in mice].
    Abalakin VA
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Jun; (6):94-9. PubMed ID: 2508379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in susceptibility of inbred mice to Bacillus anthracis.
    Welkos SL; Keener TJ; Gibbs PH
    Infect Immun; 1986 Mar; 51(3):795-800. PubMed ID: 3081444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate Immune Interactions between
    Liu JZ; Ali SR; Bier E; Nizet V
    Front Cell Infect Microbiol; 2018; 8():2. PubMed ID: 29404280
    [No Abstract]   [Full Text] [Related]  

  • 4. Pathogenesis and genetic control of resistance to the Sterne strain of Bacillus anthracis.
    Welkos SL; Friedlander AM
    Microb Pathog; 1988 Jan; 4(1):53-69. PubMed ID: 3143893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of the lethal Bacillus anthracis toxin on phagocytosis and the dynamics of the change in the enzyme activity of the antioxidative system of peritoneal mononuclear phagocytes in mice with differing hereditary immunity to anthrax].
    Abalakin VA; Sorochinskaia EP; Osipova NI; Iurkiv VA
    Biull Eksp Biol Med; 1989 Mar; 107(3):288-91. PubMed ID: 2496765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes.
    Chitlaru T; Israeli M; Rotem S; Elia U; Bar-Haim E; Ehrlich S; Cohen O; Shafferman A
    Vaccine; 2017 Oct; 35(44):6030-6040. PubMed ID: 28342664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A bivalent protein r-PB, comprising PA and BclA immunodominant regions for comprehensive protection against Bacillus anthracis.
    Majumder S; Das S; Somani V; Makam SS; Joseph KJ; Bhatnagar R
    Sci Rep; 2018 May; 8(1):7242. PubMed ID: 29740033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance of human alveolar macrophages to Bacillus anthracis lethal toxin.
    Wu W; Mehta H; Chakrabarty K; Booth JL; Duggan ES; Patel KB; Ballard JD; Coggeshall KM; Metcalf JP
    J Immunol; 2009 Nov; 183(9):5799-806. PubMed ID: 19812208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of the immunologic response induced by the Sterne 34F2 live spore Bacillus anthracis vaccine in a ruminant model.
    Ndumnego OC; Köhler SM; Crafford J; van Heerden H; Beyer W
    Vet Immunol Immunopathol; 2016 Oct; 178():14-21. PubMed ID: 27496738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of anthrax toxins in dissemination, disease progression, and induction of protective adaptive immunity in the mouse aerosol challenge model.
    Loving CL; Khurana T; Osorio M; Lee GM; Kelly VK; Stibitz S; Merkel TJ
    Infect Immun; 2009 Jan; 77(1):255-65. PubMed ID: 18955474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacillus anthracis produces membrane-derived vesicles containing biologically active toxins.
    Rivera J; Cordero RJ; Nakouzi AS; Frases S; Nicola A; Casadevall A
    Proc Natl Acad Sci U S A; 2010 Nov; 107(44):19002-7. PubMed ID: 20956325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.
    Albrecht MT; Li H; Williamson ED; LeButt CS; Flick-Smith HC; Quinn CP; Westra H; Galloway D; Mateczun A; Goldman S; Groen H; Baillie LW
    Infect Immun; 2007 Nov; 75(11):5425-33. PubMed ID: 17646360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noncapsulated toxinogenic Bacillus anthracis presents a specific growth and dissemination pattern in naive and protective antigen-immune mice.
    Glomski IJ; Corre JP; Mock M; Goossens PL
    Infect Immun; 2007 Oct; 75(10):4754-61. PubMed ID: 17635863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The assessment of antitoxic anti-anthrax immunity].
    Abalakin VA; Buravtseva NP; Neliapin NM
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Dec; (12):78-82. PubMed ID: 2129149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody against the poly-gamma-D-glutamic acid capsule of Bacillus anthracis protects mice from enhanced lethal toxin activity due to capsule and anthrax spore challenge.
    Jang J; Cho M; Lee HR; Cha K; Chun JH; Hong KJ; Park J; Rhie GE
    Biochim Biophys Acta; 2013 Mar; 1830(3):2804-12. PubMed ID: 23201204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional stimulation of anthrax toxin receptors by anthrax edema toxin and Bacillus anthracis Sterne spore.
    Xu Q; Hesek ED; Zeng M
    Microb Pathog; 2007 Jul; 43(1):37-45. PubMed ID: 17459655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to the Sterne strain of B. anthracis: phagocytic cell responses of resistant and susceptible mice.
    Welkos SL; Trotter RW; Becker DM; Nelson GO
    Microb Pathog; 1989 Jul; 7(1):15-35. PubMed ID: 2509851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anthrax toxins: A paradigm of bacterial immune suppression.
    Baldari CT; Tonello F; Paccani SR; Montecucco C
    Trends Immunol; 2006 Sep; 27(9):434-40. PubMed ID: 16861036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early interactions between fully virulent Bacillus anthracis and macrophages that influence the balance between spore clearance and development of a lethal infection.
    Cote CK; DiMezzo TL; Banks DJ; France B; Bradley KA; Welkos SL
    Microbes Infect; 2008 May; 10(6):613-9. PubMed ID: 18467145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine innate immune response to virulent toxigenic and nontoxigenic Bacillus anthracis strains.
    Drysdale M; Olson G; Koehler TM; Lipscomb MF; Lyons CR
    Infect Immun; 2007 Apr; 75(4):1757-64. PubMed ID: 17242059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.